Pentwater Capital Management’s Renalytix plc American Depositary Shares RNLX Stock Holding History
Bought
Maintained
Sold
Other funds holding RNLX
PA
LCS
TC
NCM
CF
TCM
NSIM
Pentwater Capital Management's RNLX Position: Q2 2024 in Review
Pentwater Capital Management sold out of Renalytix plc American Depositary Shares (RNLX) in Q2 2024, closing a stake of 630,000 shares — an estimated $542K sold.
Pentwater Capital Management first reported a position in RNLX in Q3 2020 and held it in 15 quarters. The position peaked at $3.09M in Q2 2021. 26 funds tracked by Wall St. Rank hold RNLX as of Q2 2024.
- Pentwater Capital Management reported no remaining Renalytix plc American Depositary Shares position as of Q2 2024 after selling out during the quarter.
- Pentwater Capital Management sold 630,000 Renalytix plc American Depositary Shares shares in Q2 2024, an estimated $542K.
- Pentwater Capital Management first reported a position in Renalytix plc American Depositary Shares in Q3 2020 and held it in 15 quarters.
- Pentwater Capital Management's Renalytix plc American Depositary Shares position peaked at $3.09M in Q2 2021.
- 26 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q2 2024.
Based on Pentwater Capital Management's 13F filing for Q2 2024, filed 31 Jul 2024.